Lipophilicity is one of the fundamental properties of a potential drug, which determines its solubility in nonpolar solvents and the occurrence of various pharmacokinetic processes, including absorption, distribution, metabolism, and excretion (ADME). CD ComputaBio is committed to providing state-of-the-art lipophilicity analysis services using best-in-class computer predictive models to assist you in efficiently screening and optimizing your drug candidate.
Lipophilicity is a fundamental property of molecules and refers to the ability of a compound to dissolve in non-polar solvents. It is usually measured by the partitioning behavior of a compound in a two-phase system such as liquid-liquid or liquid-solid, i.e., the logarithm of the octanol-water partition coefficient (log P). Lipophilicity is a property that can have a significant impact on ADME, toxicity, and pharmacological activity of a compound, so studying the lipid solubility of a test compound helps to establish the structure-activity relationship of a drug.
Fig.1 A dimensionality-reduced machine learning model for predicting single-component lipophilicity. (Kenney DH, et al.; 2023)
In the early stages of drug development, determining the lipid solubility of a test compound can help researchers identify its drugability problems and study the ADMET properties of the compound early, thereby reducing the failure rate of candidate drugs in the clinical research stage. The OECD guidelines detail log P measurements performed through different experimental protocols, such as the shake flask method and the slow stirring method. However, these traditional procedures are time-consuming, limited to extremely pure compounds, and require specific reagents. Computer prediction methods provide a promising alternative. By exploiting the large amount of information encoded in the molecular structure, these methods provide an effective way to estimate the lipophilicity of a compound without laboratory experiments.

At CD ComputaBio, our scientists use various online tools and free software to predict the lipophilicity of your molecules of interest, including ILOGP, XLOGP3, WLOGP, ALOGPS, MLOGP, and SILICOS-IT. Furthermore, we also use pkCMS and SwissADME software to determine ADME parameters to assist you in efficiently screening and optimizing your drug candidates.
Our scientists are able to interpret the lipophilicity of a wide range of molecule types, including but not limited to:
ILOGP
SwissADME
Molecular Lipophilicity Potential (MLP)

Thanks to the cutting-edge computational analysis platform, CD ComputaBio aims to provide first-class lipophilicity analysis services for your research. Our lipophilicity analysis service not only helps you predict the lipophilicity of compounds but also quickly screen out excellent candidate molecules from a large number of compounds. Please feel free to contact us, if you are interested in our services.
References:
Submit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk